Determination of related impurities in a new active pharmaceutical ingredient – Sodium 4,4′-(propanediamido)dibenzoate

2021 ◽  
Vol 168 ◽  
pp. 106498
Author(s):  
Yuliya Generalova ◽  
Nadezhda Sipkina ◽  
Galina Alekseeva
Author(s):  
Tentu Nageswara Rao ◽  
Apparao Karri ◽  
Revathi Prathipati ◽  
Parvatamma Botsa

Tolterodine is used to treat overactive bladder symptoms such as loss of bladder control (incontinence) or a frequent need to urinate. A simple and inexpensive method was developed with high performance liquid chromatography with PDA detection for determination of tolterodine and related impurities.  The chromatographic separations were achieved on (250 × 4.6 mm), 5.0 µm make: symmetry, C8 column employing methanol and 0.1% orthophosphoric acid in water, in the ratio of 90:10 as mobile phase with gradient programmed at flow rate 1.0 mL/min was chosen. Three impurities were eluted within 35 minutes. The column temperature was maintained at 35oC and a detector wavelength of 220 nm was employed. The method was successfully validated by establishing system suitability, specificity, linearity, accuracy, LOD and LOQ. The validated method is useful for tolterodine assay in pharmaceutical products. 


2018 ◽  
Vol 34 (5) ◽  
pp. 2425-2434
Author(s):  
Santosh T. Khadangale ◽  
Vitthal M. Dhalape ◽  
Rahul V. Pinjari

Dexrabeprazole sodium (DEX•Na) is an active pharmaceutical ingredient and used as proton pump inhibitor. A reverse phase (RP) ultra-performance liquid chromatographic (UPLC) method is developed for determination of related impurities in DEX•Na and this method is validated using ICH guideline. This method was developed using BEH C18 (2.1 X 50 mm) 1.7 µm column and gradient program for mobile phase. Mobile phase A contains 99% phosphate buffer of pH ~7.0 and 1% acetonitrile, whereas mobile phase B is the methanol and acetonitrile in 95:5 ratio. The 0.45 mL/min total flow rate, 3.0 µL injection volume, 40°C column oven temperature and 284 nm detection wavelength are used with sampling rate of 5 points per second. The DEX•Na peak is well separated from its known and unknown impurities. The run time of the method is reduced to 10 min, which is ~11 times smaller than methods reported in literature. The method is accurate and precise as well as linear in the range of LOQ to 150% level with respect to specification concentration limit of impurities. The stress conditions to DEX•Na revealed that drug is stable in alkaline medium, while it is sensitive to acidic and oxidative condition. The new method is sensitive, precise, accurate, and rapid; it also qualifies all the criteria of linearity, stability, as well as robustness.


2020 ◽  
Vol 16 ◽  
Author(s):  
Yun-Yan Xia ◽  
Qiao-Gen Zou ◽  
Yu-Fei Yang ◽  
Qian Sun ◽  
Cheng-Qun Han

Background: High-performance liquid chromatography (HPLC) method has been used to detect related impurities of perampanel. However, the detection of impurities is incomplete, and the limits of quantification and detection are high. A sensitive, reliable method is in badly to be developed and applied for impurity detection of perampanel bulk drug. Objective: Methodologies utilising HPLC and gas chromatography (GC) were established and validated for quantitative determination of perampanel and its related impurities (a total of 10 impurities including 2 genotoxic impurities). Methods: The separation was achieved on a Dikma Diamonsil C18 column (250 mm × 4.6 mm, 5 μm) with the mobile phase of 0.01 mol/L potassium dihydrogen phosphate solution (A) and acetonitrile (B) in gradient elution mode. The compound 2-bromopropane was determined on an Agilent DB-624 column (0.32 mm × 30 m, 1.8 μm) by electron capture detector (μ-ECD) with split injection ratio of 1:5 and proper gradient temperature program. Result: Both HPLC and GC methods were established and validated to be sensitive, accurate and robust according to International Council for Harmonization (ICH) guidelines. The methods developed were linear in the selected concentration range (R 2≥0.9944). The average recovery of all impurities was between 92.6% and 103.3%. The possible production mechanism of impurities during the synthesis and degradation processes of perampanel bulk drug was also discussed. Five impurities were analyzed by liquid chromatography–mass spectrometry (LC-MS). Moreover, two of them were simultaneously characterized by LC-MS, IR and NMR. Conclusion: The HPLC and GC methods were developed and optimized, which could be applied for quantitative detection of the impurities, and further stability study of perampanel.


RSC Advances ◽  
2021 ◽  
Vol 11 (35) ◽  
pp. 21332-21342
Author(s):  
Ibrahim A. Naguib ◽  
Eglal A. Abdelaleem ◽  
Eman S. Hassan ◽  
Aml A. Emam

Zero order absorption spectra of 12 μg mL−1 of Dacarbazine (), 5-amino-imidazole-4 carboxamide (), and 2-azahypoxanthine (…) using sterile water as a blank.


2016 ◽  
Vol 39 (7) ◽  
pp. 937-945
Author(s):  
Yi Soo Kim ◽  
Sung Joong Lee ◽  
Jin Young Choi ◽  
Yun-Hi Kim ◽  
Kebede Taye Desta ◽  
...  

Author(s):  
Ashok B. Patel ◽  
Ekta H. Vaghasiya ◽  
Amit R. Dudhatra ◽  
Amitkumar J. Vyas ◽  
Ajay I. Patel ◽  
...  

Stability indicating RP-UPLC photo diode array detector based method for determination of Dapagliflozin propanediol monohydrate (DPM) in active pharmaceutical ingredient (API) and in tablet dosage form (5mg dapagliflozin) has been developed and validated on Bridge Ethylene Hybride (BEH) C18 column (50mm × 2.1 mm, 1.7µm). Mobile phase composition was water: acetonitrile (60:40 v/v), flow rate 0.5ml/min and detection carried out at 223nm at column temperature 30ºC. Chromatographic separation achieved within 2 min with retention time 0.77 min. Linearity of the method was found over the concentration range of 25-75µg/ml (R2 = 0.9977). The degradation was carried out in five different stress conditions. The developed method was able to resolve peak of API from all generated peaks. Sufficient degradation was achieved in the range of 5.25 to 12.31%. The peak purity is acceptable, Method validation was performed as per ICH guideline Q2(R1).


Author(s):  
Murat Soyseven ◽  
Rüstem Keçili ◽  
Hassan Y Aboul-Enein ◽  
Göksel Arli

Abstract A novel analytical method, based on high-performance liquid chromatography with a UV (HPLC-UV) detection system for the sensitive detection of a genotoxic impurity (GTI) 5-amino-2-chloropyridine (5A2Cl) in a model active pharmaceutical ingredient (API) tenoxicam (TNX), has been developed and validated. The HPLC-UV method was used for the determination of GTI 5A2Cl in API TNX. The compounds were separated using a mobile phase composed of water (pH 3 adjusted with orthophosphoric acid): MeOH, (50:50: v/v) on a C18 column (150 × 4.6 mm i.d., 2.7 μm) at a flow rate of 0.7 mL min−1. Detection was carried out in the 254 nm wavelength. Column temperature was maintained at 40°C during the analyses and 10 μL volume was injected into the HPLC-UV system. The method was validated in the range of 1–40 μg mL−1. The obtained calibration curves for the GTI compound was found linear with equation, y = 40766x − 1125,6 (R2 = 0.999). The developed analytical method toward the target compounds was accurate, and the achieved limit of detection and limit of quantification values for the target compound 5A2Cl were 0.015 and 0.048 μg mL−1, respectively. The recovery values were calculated and found to be between 98.80 and 100.03%. The developed RP-HPLC-UV analytical method in this research is accurate, precise, rapid, simple and appropriate for the sensitive analysis of target GTI 5A2Cl in model API TNX.


2015 ◽  
pp. bmv125 ◽  
Author(s):  
Eglal A. Abdelaleem ◽  
Ibrahim A. Naguib ◽  
Hala E. Zaazaa ◽  
Essraa A. Hussein

Sign in / Sign up

Export Citation Format

Share Document